Abstract
Objectives
To develop and validate an automatic classification algorithm for diagnosing Alzheimer’s disease (AD) or mild cognitive impairment (MCI).
Methods and materials
This study evaluated a high-performance interpretable network algorithm (TabNet) and compared its performance with that of XGBoost, a widely used classifier. Brain segmentation was performed using a commercially approved software. TabNet and XGBoost were trained on the volumes or radiomics features of 102 segmented regions for classifying subjects into AD, MCI, or cognitively normal (CN) groups. The diagnostic performances of the two algorithms were compared using areas under the curves (AUCs). Additionally, 20 deep learning–based AD signature areas were investigated.
Results
Between December 2014 and March 2017, 161 AD, 153 MCI, and 306 CN cases were enrolled. Another 120 AD, 90 MCI, and 141 CN cases were included for the internal validation. Public datasets were used for external validation. TabNet with volume features had an AUC of 0.951 (95% confidence interval [CI], 0.947–0.955) for AD vs CN, which was similar to that of XGBoost (0.953 [95% CI, 0.951–0.955], p = 0.41). External validation revealed the similar performances of two classifiers using volume features (0.871 vs. 0.871, p = 0.86). Likewise, two algorithms showed similar performances with one another in classifying MCI. The addition of radiomics data did not improve the performance of TabNet. TabNet and XGBoost focused on the same 13/20 regions of interest, including the hippocampus, inferior lateral ventricle, and entorhinal cortex.
Conclusions
TabNet shows high performance in AD classification and detailed interpretation of the selected regions.
Clinical relevance statement
Using a high-performance interpretable deep learning network, the automatic classification algorithm assisted in accurate Alzheimer’s disease detection using 3D T1-weighted brain MRI and detailed interpretation of the selected regions.
Key Points
• MR volumetry data revealed that TabNet had a high diagnostic performance in differentiating Alzheimer’s disease (AD) from cognitive normal cases, which was comparable with that of XGBoost.
• The addition of radiomics data to the volume data did not improve the diagnostic performance of TabNet.
• Both TabNet and XGBoost selected the clinically meaningful regions of interest in AD, including the hippocampus, inferior lateral ventricle, and entorhinal cortex.
Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer’s disease
- ADNI:
-
Alzheimer Disease Neuroimaging Initiative
- AIBL:
-
Australian Imaging Biomarkers and Lifestyle Study of Aging
- AUC:
-
Area under the curve
- CDR:
-
Clinical dementia rating
- CN:
-
Cognitive normal
- MCI:
-
Mild cognitive impairment
References
Nichols E, Szoeke CE, Vollset SE et al (2019) Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:88–106
Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279
Dubois B, Feldman HH, Jacova C et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. Lancet Neurol 6:734–746
McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269
Fink HA, Linskens EJ, Silverman PC et al (2020) Accuracy of biomarker testing for neuropathologically defined Alzheimer disease in older adults with dementia: a systematic review. Ann Intern Med 172:669–677
Yamashita R, Nishio M, Do RKG, Togashi K (2018) Convolutional neural networks: an overview and application in radiology. Insights Imaging 9:611–629
Suh C, Shim W, Kim S et al (2020) Development and validation of a deep learning–based automatic brain segmentation and classification algorithm for Alzheimer disease using 3D T1-weighted volumetric images. AJNR Am J Neuroradiol 41:2227–2234
Arık SO, Pfister T (2020) Tabnet: attentive interpretable tabular learning. arXiv:190807442v5
Chen T, Guestrin C (2016) Xgboost: a scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining, pp 785–794. https://doi.org/10.1145/2939672.2939785
Jack CR Jr, Albert MS, Knopman DS et al (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:257–262
Mueller SG, Weiner MW, Thal LJ et al (2005) The Alzheimer’s disease neuroimaging initiative. Neuroimaging Clin N Am 15:869–877
Fischl B (2012) FreeSurfer. Neuroimage 62:774–781
Van Griethuysen JJ, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Can Res 77:e104–e107
Shwartz-Ziv R, Armon A (2022) Tabular data: deep learning is not all you need. Inf Fusion 81:84–90
DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845
Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32–35
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Methodol) 57:289–300
Ribeiro MT, Singh S, Guestrin C (2016) Why should I trust you? Explaining the predictions of any classifier. In Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining, pp 1135–1144. https://doi.org/10.48550/arXiv.1602.04938
Kong H-J (2019) Managing unstructured big data in healthcare system. Healthc Inform Res 25:1–2
Jo T, Nho K, Saykin AJ (2019) Deep learning in Alzheimer’s disease: diagnostic classification and prognostic prediction using neuroimaging data. Front Aging Neurosci 20(11):220
Yang H, Xu H, Li Q et al (2019) Study of brain morphology change in Alzheimer’s disease and amnestic mild cognitive impairment compared with normal controls. Gen Psychiatry 32(2):e100005
Poulin SP, Dautoff R, Morris JC, Barrett LF, Dickerson BC, AsDN I (2011) Amygdala atrophy is prominent in early Alzheimer’s disease and relates to symptom severity. Psychiatry Res Neuroimaging 194:7–13
Choi JD, Moon Y, Kim H-J, Yim Y, Lee S, Moon W-J (2022) Choroid plexus volume and permeability at brain MRI within the Alzheimer disease clinical spectrum. Radiology 304(3):635–645
Schippers MC, Bruinsma B, Gaastra M et al (2017) Deep brain stimulation of the nucleus accumbens core affects trait impulsivity in a baseline-dependent manner. Front Behav Neurosci 11:52
Pievani M, Bocchetta M, Boccardi M et al (2013) Striatal morphology in early-onset and late-onset Alzheimer’s disease: a preliminary study. Neurobiol Aging 34:1728–1739
Nie X, Sun Y, Wan S et al (2017) Subregional structural alterations in hippocampus and nucleus accumbens correlate with the clinical impairment in patients with Alzheimer’s disease clinical spectrum: parallel combining volume and vertex-based approach. Front Neurol 8:399
Feng Q, Ding Z (2020) MRI radiomics classification and prediction in Alzheimer’s disease and mild cognitive impairment: a review. Curr Alzheimer Res 17:297–309
Ranjbar S, Velgos SN, Dueck AC, Geda YE, Mitchell JR, AsDN I (2019) Brain MR radiomics to differentiate cognitive disorders. J Neuropsychiatry Clin Neurosci 31:210–219
Achterberg HC, van der Lijn F, den Heijer T et al (2014) Hippocampal shape is predictive for the development of dementia in a normal, elderly population. Hum Brain Mapp 35:2359–2371
Sørensen L, Igel C, Liv Hansen N et al (2016) Early detection of Alzheimer’s disease using M RI hippocampal texture. Hum Brain Mapp 37:1148–1161
Won SY, Park YW, Park M, Ahn SS, Kim J, Lee S-K (2020) Quality reporting of radiomics analysis in mild cognitive impairment and Alzheimer’s disease: a roadmap for moving forward. Korean J Radiol 21:1345–1354
Ferreira D, Nordberg A, Westman E (2020) Biological subtypes of Alzheimer disease: a systematic review and meta-analysis. Neurology 94:436–448
Ferreira D, Verhagen C, Hernández-Cabrera JA et al (2017) Distinct subtypes of Alzheimer’s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications. Sci Rep 7:1–13
Funding
This work was supported by the National Research Foundation of Korea (NRF-2021R1C1C1014413 to Chong Hyun Suh).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Chong Hyun Suh, M.D.
Conflict of interest
Hyun Woo Oh, M.S.; Kim Jingyoung, M.S.; and Jinkyeong Sung, M.D., Ph.D. are employees of VUNO Inc. The authors report no other conflicts of interest, and the present study has not been presented elsewhere.
Statistics and biometry
One of the authors has significant statistical expertise.
Informed consent
Written informed consent was not required due to the retrospective nature of the study.
Ethical approval
This study was approved by the institutional review board of Asan Medical Center.
Methodology
• Retrospective
• Diagnostic or prognostic study
• Performed at one institution
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Park, H.Y., Shim, W.H., Suh, C.H. et al. Development and validation of an automatic classification algorithm for the diagnosis of Alzheimer’s disease using a high-performance interpretable deep learning network. Eur Radiol 33, 7992–8001 (2023). https://doi.org/10.1007/s00330-023-09708-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-023-09708-8